Study Of A Ribonuclease And Its Inhibitor From Bacillus
Study Of A Ribonuclease And Its Inhibitor From Bacillus
批准号:
6532081
负责人:
ROBERT W HARTLEY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Bacillus Streptomyces bacterial proteins chemical stability enzyme activity enzyme biosynthesis enzyme inhibitors enzyme mechanism enzyme structure esterase inhibitor exoribonucleases gene expression gene mutation genetic manipulation genetic regulatory element intermolecular interaction microorganism metabolism molecular cloning nucleic acid chemical synthesis nucleic acid sequence protein engineering protein folding protein protein interaction protein structure function recombinant DNA site directed mutagenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Two proteins, barnase, the extracellular ribonuclease of Bacillus amyloliquefaciens, and barstar, its intracellular inhibitor, are used as a model system for the study of protein folding and protein-protein interactions. Barnase is one of a homologous group of ribonucleases occurring in both prokaryotes and eukaryotes. Recombinant DNA techniques are being applied with three major aims: (1) to facilitate production of wild type and mutant proteins; (2) to examine the structural and control sequences of the genes; and (3) to make specific changes in the sequences to test theories of folding and to probe the barnase-barstar interaction. Both proteins can now be obtained from recombinant genes in E. coli where expression of barstar counters the lethal effect of barnase expression. The structures of both proteins and their complex are known, barnase at 1.5 Angstrom resolution. Crystal structures of several barnase-barstar pairs having complementary mutations in the interface, obtained by an in vivo selective technique, have been solved, providing insight into the mechanisms that determine the strength of the bond. Barstar also inhibits a group of RNases from Streptomyces strains. These enzymes are distantly related to barnase with a sequence identity of only 25%. Among the four such enzymes in hand, identities range from 40% to 70%. The structures of two, RNases Sa and St, are known from work on nonrecombinant material and a third, RNase Sa2, from our recombinant material. The structure of recombinant RNase Sa in complex with barstar has also been solved. Two barstar homologs from streptomyces, for Sa2, have been cloned and expressed and since RNase St of S. erythreus is insufficiently inhibited by barstar, its homologous inhibitor is being actively pursued. The gene yrdF, identified in the complete sequence of B. subtilis 168 as similar to that of barstar, has been cloned and, after several codon modifications, expressed in E. coli. Although there is no recognizable homolog of barnase in B. subtilis 168, yrdF is an effective inhibitor, in vitro and in vivo, of barnase. The dissociation constants (Kd) of the two Sa inhibitors complexed with barnase are 3x10exp-11 and 3x10exp-10, compared to no more than 10exp-12 for yrdH and 6x10exp-14 for barstar. A phage display system has been developed for selection of varieties or homologs of barstar that bind tightly to barnase or its mutants. Procedures have been developed for total synthesis of the barstar gene with randomization of selected residues and a multiplicity (the number of independently randomized sequences) on the order of 10exp9. We have screened 3 synthetic barstar libraries with spatially compact 8, 11 and 11 residue portions of the hydrophobic core randomized and another with randomization of all 22 residues of the core. The possible residues in each substituted position were Leu, Ile, Val, Met or Phe. Unselected genes transferred to a plasmid barstar vector showed no indication of functional barstar, while all selected genes appear to be functional in vivo, allowing transformation of their host by a compatible plasmid carrying barnase. All of the latter also produce measurable barstar activity in vitro, most at a very low level. Some of each set, however, do produce enough for physical studies. Sequencing of a large number of these genes has commenced and as many as practicable will be chosen for physical, functional and structural studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study Of A Ribonuclease And Its Inhibitor From Bacillus
-
批准号:6673341
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT W HARTLEY
-
依托单位:
Study Of A Ribonuclease And Its Inhibitor From Bacillus
-
批准号:6809835
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:6289714
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT W HARTLEY
-
依托单位:
Study Of A Ribonuclease And Its Inhibitor From Bacillus
-
批准号:6983601
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:6432055
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:6104998
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT W HARTLEY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Streptomyces rochei D21E05 次级代谢产物分离纯化及其活性功能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:关鹏
-
依托单位:
Streptomyces rimosus M527特异性高强度合成龟裂霉素的多模块协同改造
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:马正
-
依托单位:
深海放线菌Streptomyces sp. 11695的抗菌活性次级代谢产物基因组挖掘
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:罗明和
-
依托单位:
基于TAG途径解析 Streptomyces exfoliates A1013Y中蓝色素代谢调控分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:朱运平
-
依托单位:
基因导向的海洋链霉菌Streptomyces sp. LC13中次级代谢产物的挖掘和bacaryolane C的生物合成研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:朱宏杰
-
依托单位:
放线菌Streptomyces mediolani EM-B2的生物脱氮机理研究
-
批准号:42167019
-
项目类别:地区科学基金项目
-
资助金额:36万元
-
批准年份:2021
-
负责人:何腾霞
-
依托单位:
链霉菌新菌株Streptomyces samsunensis F2农用抗生素先导物发掘及生防机制研究
-
批准号:2020JJ4386
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:刘红艳
-
依托单位:
天目山来源链霉菌Streptomyces sp. SY1322中morindolestatin类新颖咔唑生物碱获取及其铁死亡抑制活性研究
-
批准号:LY21H300001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:马列峰
-
依托单位:
Streptomyces sp. Gö66 中基于基因组挖掘的新颖非核糖体肽的发现及生物合成机制的研究
-
批准号:31972852
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:蔡晓凤
-
依托单位:
链霉菌Streptomyces sp. G0051B 中膦酸类抗生素Argolaphos A的生物合成研究
-
批准号:31870050
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:高江涛
-
依托单位: